肝胆管结石三维可视化精准诊治专家共识(2019版)

2019-10-30 中华医学会数字医学分会 中国实用外科杂志.2019,39(10):1001-1009.

为规范三维可视化技术在肝胆管结石临床诊治中的应用,中华医学会数字医学分会和中国研究型医院学会数字医学临床外科专业委员会等组织国内专家于2017年制定了《肝胆管结石三维可视化精准诊治专家共识(2017版)》,该共识指导临床应用2年来,有力推动了我国肝胆管结石病外科精准诊治,同时也发现了一些阐述尚不够清晰,内容尚不够完善的问题。鉴于此,共识编委会依据现有文献和国内专家意见,对该共识进行修订和更新,以期

中文标题:

肝胆管结石三维可视化精准诊治专家共识(2019版)

发布日期:

2019-10-30

简要介绍:

为规范三维可视化技术在肝胆管结石临床诊治中的应用,中华医学会数字医学分会和中国研究型医院学会数字医学临床外科专业委员会等组织国内专家于2017年制定了《肝胆管结石三维可视化精准诊治专家共识(2017版)》,该共识指导临床应用2年来,有力推动了我国肝胆管结石病外科精准诊治,同时也发现了一些阐述尚不够清晰,内容尚不够完善的问题。鉴于此,共识编委会依据现有文献和国内专家意见,对该共识进行修订和更新,以期更好地指导我国相关工作的开展。

 

拓展指南:肝胆相关指南:

下载附件:

(因为版权问题,不支持下载)

评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=917052, encodeId=582d91e052da, content=很详细啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200820/a50c79dfbf8443c28d9507e5ed481752/4f3848e242344bd8a14c3db699d30a7b.jpg, createdBy=da5f5248805, createdName=Mr.d, createdTime=Sat Jan 16 00:52:26 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804500, encodeId=091b804500d8, content=6666666啊,厉害啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b8f1961917, createdName=a6806376, createdTime=Sat Jul 25 11:46:27 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804499, encodeId=bc8f80449945, content=66666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b8f1961917, createdName=a6806376, createdTime=Sat Jul 25 11:46:13 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375347, encodeId=99893e5347ff, content=非常受益,很好的研究, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Sat Nov 16 19:02:28 CST 2019, time=2019-11-16, status=1, ipAttribution=)]
    2021-01-16 Mr.d

    很详细啊

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=917052, encodeId=582d91e052da, content=很详细啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200820/a50c79dfbf8443c28d9507e5ed481752/4f3848e242344bd8a14c3db699d30a7b.jpg, createdBy=da5f5248805, createdName=Mr.d, createdTime=Sat Jan 16 00:52:26 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804500, encodeId=091b804500d8, content=6666666啊,厉害啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b8f1961917, createdName=a6806376, createdTime=Sat Jul 25 11:46:27 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804499, encodeId=bc8f80449945, content=66666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b8f1961917, createdName=a6806376, createdTime=Sat Jul 25 11:46:13 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375347, encodeId=99893e5347ff, content=非常受益,很好的研究, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Sat Nov 16 19:02:28 CST 2019, time=2019-11-16, status=1, ipAttribution=)]
    2020-07-25 a6806376

    6666666啊,厉害啊

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=917052, encodeId=582d91e052da, content=很详细啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200820/a50c79dfbf8443c28d9507e5ed481752/4f3848e242344bd8a14c3db699d30a7b.jpg, createdBy=da5f5248805, createdName=Mr.d, createdTime=Sat Jan 16 00:52:26 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804500, encodeId=091b804500d8, content=6666666啊,厉害啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b8f1961917, createdName=a6806376, createdTime=Sat Jul 25 11:46:27 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804499, encodeId=bc8f80449945, content=66666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b8f1961917, createdName=a6806376, createdTime=Sat Jul 25 11:46:13 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375347, encodeId=99893e5347ff, content=非常受益,很好的研究, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Sat Nov 16 19:02:28 CST 2019, time=2019-11-16, status=1, ipAttribution=)]
    2020-07-25 a6806376

    66666

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=917052, encodeId=582d91e052da, content=很详细啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200820/a50c79dfbf8443c28d9507e5ed481752/4f3848e242344bd8a14c3db699d30a7b.jpg, createdBy=da5f5248805, createdName=Mr.d, createdTime=Sat Jan 16 00:52:26 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804500, encodeId=091b804500d8, content=6666666啊,厉害啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b8f1961917, createdName=a6806376, createdTime=Sat Jul 25 11:46:27 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804499, encodeId=bc8f80449945, content=66666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b8f1961917, createdName=a6806376, createdTime=Sat Jul 25 11:46:13 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375347, encodeId=99893e5347ff, content=非常受益,很好的研究, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Sat Nov 16 19:02:28 CST 2019, time=2019-11-16, status=1, ipAttribution=)]
    2019-11-16 14794e5bm67(暂无昵称)

    非常受益,很好的研究

    0